Johnson & Johnson weighs $20B+ DePuy Synthes sale: medtech shake-up

Welcome back to Breaking News to Trading Moves: Long and short trading ideas.

Today’s headline: Johnson & Johnson is exploring a potential sale of its orthopedics unit, DePuy Synthes, in a deal that could top $20B.

What happened

$JNJ is preparing for a possible sale of DePuy Synthes, with private equity seen as the most likely buyer group. The company is reportedly getting financials and documents ready ahead of meetings with potential buyers in the coming weeks.

This is notable because $JNJ previously said it planned to separate the orthopedics unit into a standalone company within 18–24 months, but it’s signaling it may be open to other paths.

Why this matters for markets

1. Portfolio reshuffle, faster tha ...